HENDERSON, Nev.–(BUSINESS WIRE)–Oct. 23, 2018– Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today…Original Article
Spectrum Pharmaceuticals Receives FDA Approval of Khapzory (levoleucovorin) for Injection
